WHO ARE WE?
FHC | Farmacêutica leads FHC Group, holding a set of subsidiaries, that act transversally in the human health area.
A global group
Constitution of FHC Farmacêutica
Entrance in the share capital of Empifarma
Entrance in the share capital of Overpharma
Expansion of FHC Farmacêutica logistics facilities to 1,500 m³, in Mortágua
Acquisition of financial participation in Laboratórios Basi and beginning of products distribution in the national market
Constitution of Phagecon, a company dedicated to providing services to the pharmaceutical sector
Acquisition of the total capital of Laboratórios BASI
Creation of Actrádia, S.A, a company dedicated to the management of the group’s real estate assets
Transformation of Empifarma in a public limited company and beginning of the pre-wholesale operation
Constitution of Zeone, a company dedicated to the provision of services and consultancy in the IT area
Construction of a Quality Control laboratory for Laboratórios Basi, with GMP approval, in Mortágua
Construction of the new Liquid and Semi-solid Production Unit of Laboratórios Basi, in Mortágua
Constitution of Actrádia Consultoria, a company dedicated to providing shared services
Acquisition of the total capital of Paracélsia
Development, by Zeone, of the B2B software Magium Farma
Empifarma acquires a Knapp's robotic logistics unit, with 9,000 m2 of covered area, in Montemor-o-Velho and begins the operation of general distribution (pharmacies) and promotion through Magium
Acquisition of 100% of the company Laphysan (Spain), a company dedicated to the distribution and marketing of pharmaceutical products
Design of the Project for the Production Unit of Injections of Laboratórios Basi, in Mortágua
Construction of the Production Unit of Injections of Laboratórios Basi in Mortágua
Manufacturer’s Authorisation (EudraGMP) for the Production unit of Injections of Laboratórios Basi, in Mortágua
Empifarma completes the expansion project of a new Knapp’s robotic logistics unit, in Famões (Lisbon)
FHC, having a deep knowledge in the pharmaceutical supply chain, allowed a quick and effective action in the response to COVID-19, supplying the necessary equipment to several countries and national health authorities to contain the spread of the virus
Basi became members of iBET – Instituto de Biologia Experimental e Tecnológica and obtained certification in Quality (NP EN ISO 9001:2015), Environment (NP BN ISO 14001:2015) and Safety (ISO 4500:2018)
Constitution of Basinnov Life Sciences
Implementation of the ISO 50001:2018 Energy Management Process, in Basi
Basi obtained Recognition of Suitability in terms of Research and Development, by ANI
Acquisition of a financial stake in the company Mozpharma (MZ)
Basi announces a strategic investment and partnership with TargTex, a private biotechnology company which develops an innovative and novel treatment for brain tumours
Basi and Beta-i • collaborative innovation launches global co-innovation program for oncology and immunotherapy
Creation of Pharma Academy, Training Academy
Requalification of the Headquarters Building of the FHC Group
Acquisition of a financial stake in the company Grasshopper (PT)
Constitution of SVP Pharma (UK)
Constitution of Guinepharma (GE)
Constitution of Vitamed (BR)
Acquisition of a financial stake in the company Worldrugs (PT)
Acquisition of a financial stake in the company Socifarma (AO)
Acquisition of a financial stake in the company Mecofama (AO)
Disposal of a financial stake in the company Phagecon (PT)
Disposal of a financial stake in the company Saluspharma (GW e ST)
FHC Group in numbers
Forecast Aggregate Financial Indicators 2023
Areas of Activity
Where are we?
We are present directly in 7 geographies, which allows us to operate in an integrated way in these markets, from consulting and monitoring services in Pharmaceutical Regulatory Affairs, to promotion and local Logistics & Distribution operations.
WHAT DO WE DO?
We have a deep knowledge and a wide network in the pharmaceutical sector, allowing us to have a broad global vision and to provide a wide spectrum of healthcare products suited to the needs of each market and under the best conditions, enabling the treatment of millions of people across the world.
The excellence and quality of what we do, allowed us to build a relationship of great trust with our clients and partners.
We believe that the access to quality and affordable healthcare is everyone’s right. We contribute to improve the access to quality healthcare for millions of people around the world.
FHC | Farmacêutica
Because we believe in what we do. Our driving force is the passion for challenge, energy and belief. Our commitment is to remain true to our principles focused on the continuous improvement of our processes and the simplification of our operations.
We exist to create sustainable value.
Access to quality healthcare
Level of service
Our B2B Portal allows to visualise, on time, the status of client’s orders, check shipments and have access to the documentation, verify the movements and have access to all documents of their current account.
Quality, environment and safety
With a consolidated international presence, we recognize that the impacts associated with the life cycle of our activity are particularly relevant.
Our greatest strength lies in the detailed knowledge of the markets and the quality of the products sold.
It is on these assumptions that FHC bases its sustainability strategy, guaranteeing the necessary balance to satisfy the needs of its customers, while promoting a socially responsible and environmental protection policy.
To this end, we highlight 5 areas in which we are more clearly committed:
Commitment to its human resources as a clearly differentiating factor due to its quality, delivery and vision;
Optimization of the distribution chain, enhancing the cargo transported and the defined route;
Promotion of circular economy principles, ensuring the extension of the useful life of materials and the selection of products with incorporated recycled material and with less environmental impact;
Energy management of facilities, through the definition of means of proximity control in order to ensure efficient use of available resources.
An ambitious project to produce energy for self-consumption is under way, which will allow us to significantly reduce dependence on non-renewable resources.
In early 2023, FHC successfully completed the certification process for the ISO 14001 – Environmental Management and ISO 45001 – Occupational Health and Safety Management standards, now having, together with the certification in Quality Management – ISO 9001, a Integrated Management System, which will allow us to reinforce the efficiency of the organization's internal processes and responses to the numerous requests we are confronted with.
We know our value and the extent to which our contribution can go, whether in the operation we develop or in the capacity for influence that we seek to promote with our partners, which is why we remain committed to significantly advancing the goal of carbon neutrality.
For each new goal achieved, we renew our responsibility and ambition to do even more and better.
We are permanently focused on continuously improving our performance, aimed at:
Ensure the client's satisfaction through a variety of customised services and the offer of innovative, quality, safe, effective products, that meet the wanted performance or claim;
Optimise the performance of the processes and of the Management System through the best possible use of the resources and technologies available and through effective planning, in order to obtain business and energy performance advantage;
Distribute resources effectively for the performance of the internal activities, in order to promote creation of value for the shareholders ensuring continuous monitoring of the economic-financial performance and continuously promoting the improvement of the internal processes in order to obtain productivity and improvement of the energy performance;
Promotion of the continuous improvement in the performance of the Management System and its processes, through the optimisation of the allocation of the resources and technologies available as well as the use of the best planning practices;
Anticipate and diversify, through permanent control, close to the market, in order to continuously adapt the offer of products and services in accordance with its needs, allowing the implementation of an activity oriented to the “innovation at the client’s service”;
Promote the management of scientific, technological, organisational, financial and commercial (including investment in new technologies) activities, aligned with the implementation of Innovation, supported in the design and acquisition of products and services energetically efficient;
Ensure compliance with legal, regulatory and other requirements that organization subscribes, and compliance with the requirements agreed with stakeholders;
Promote the continuous improvement of the environmental performance, through the identification and control of the environmental aspects controlled by the organisation and through its influence, regarding the offer of products and services, preventing pollution;
Promote the continuous improvement of the Safety and Health at work conditions, through the identification and control of risks and prevention of occurrence of accidents (at work);
Promote the involvement of all employees in the purposes and growth strategies of the company, through the promotion of creativity, communication and activities of collaboration, consultation and participation.
Lote 2/10, Apartado 45